SSDP considers that the 'drugs cost lives' narrative, although well-meaning, is stigmatising and harmful, and fuels damaging approaches based on prohibition, punishment and criminalisation.
Rêgo et al. argue that, despite the positive progress enabled by the Portuguese model, its limited ambitions, lack of update, and regressions toward punitive responses have severely undermined its potential.
Kvamme et al. suggest that a significant proportion of Danish users of cannabis as medicine are motivated by a desire to alleviate their ailments whilst minimising the negative side effects that they associate with legal prescription drugs.
EMCDDA explores the epidemiology of drug-related health problems in prisons, discussing available harm reduction measures and persistent challenges in these settings.
Grisaffi et al. argue that the successes of coca regulation in Bolivia could be replicated in Peru, as long as efforts centre community empowerment and participation.
The 64th session of the CND was marked by the increase in prominence of health and human rights narratives, the proceedings' 'hybrid format' and a welcome long-overdue shift in the US stance on harm reduction.
Dame Carol Black analyses trends and impact of thriving informal drug markets in England, and provides recommendations on how to address health-related challenges.
